On this planet, there are zillions of patients who are seeking specialty medications, orphan medicines, or unlicensed medicines. We (IKRIS Pharma Network) are certified by WHO-GDP and can provide patients with prompt access to their medications.
Worldwide access to Specific & Lifesaving Medicines has been made easiest because of Named Patient Medicines (NPM). IKRIS Pharma Network advocates for Named Patient Services in India helping Patients, Doctors, and Hospitals.
Named Patient Services/Supply essentially helps Indian patients to experience the clinical benefits of new and latest medicines approved by the FDA and EMA. It is believed that many of the drugs imported into India under the provisions of Named Patient Medicines (NPM) are Lifesaving in nature. Moreover, there are several therapeutic choices that can be helpful in elongating survival and enhancing the quality of life (QoL).
Because of the legal provisions of importing medicines for personal use in India, eligible patients need not wait for the appropriate treatment options to be formally available. IKRIS Pharma Network (IPN), facilitates end-to-end import procedures for the benefit of patients seeking novel therapy solutions.
Being one of the limited GDP-certified distributors or Named Patient Medicine Suppliers from India, IKRIS is completely committed to helping patients and their caregivers living with rare diseases with as easy as pie access to these lifesaving medicines.
If you are looking for certain specific medicines which are not available in India? We would like to help you. Kindly Call/WhatsApp: +91 9310090915 or dial our TOLL-FREE: 1800-889-1064 to know more about our Named Patient Program (NPP)/Named Patient Medicine Supply. At IKRIS, we have an experienced team and professionally run top-notch infrastructure to distribute/supply special medicines worldwide.